To our knowledge, this is the first study evaluating the role of P-Rex1 in neuroblastoma (or any solid tumor predominantly diagnosed in children) and describing its potential as a novel therapeutic management strategy in neuroblastic tumors. Here, PREX1 is linked to neuroblastic tumor.